Segment Information

9 Months Ended

Jun. 28, 2013

Segment Information

17. SEGMENT INFORMATION

The Company’s operations are grouped into two reportable operating segments: Oncology Systems and X-ray Products. These reportable operating segments were determined based on how the Company’s Chief Executive Officer, its Chief Operating Decision Maker (“CODM”), views and evaluates the Company’s operations. The Company’s Ginzton Technology Center, Security and Inspection Products business and Varian Particle Therapy business are reflected in the “Other” category because these operating segments do not meet the criteria of a reportable operating segment. The CODM allocates resources to and evaluates the financial performance of each operating segment primarily based on operating earnings.

The following table summarizes selected operating results information for each business segment:

	ThreeMonthsEnded						NineMonthsEnded
(In millions)	June28, 2013			June29, 2012			June28, 2013			June29, 2012
Revenues
Oncology Systems	$	561		$	546		$	1,667		$	1,599
X-ray Products		136			127			409			363
Total reportable segments	$	697		$	673		$	2,076		$	1,962
Other		29			32			97			89
Total company	$	726		$	705		$	2,173		$	2,051
Operating Earnings (Loss)
Oncology Systems	$	129		$	127		$	381		$	364
X-ray Products		33			35			105			94
Total reportable segments	$	162		$	162		$	486		$	458
Other		(4	)		(8	)		(22	)		(27	)
Corporate		(3	)		—			(16	)		(5	)
Total company	$	155		$	154		$	448		$	426